To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCM2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
512 supporting clones for gene CCM2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ073060 leukocyte CCM2.a 1 to 915 1 to 927   tiling clone,   927/1070
(86 %)
28 diff
(97.4 %id)
CF145050 CNCAP(3)T-225 cell line, Prostate CCM2.a 564 to 1013 8 to 457       450/457
(98 %)
10 diff
(97.9 %id)
CF145136 CNCAP(3)T-225 cell line, Prostate CCM2.a 564 to 972 8 to 416       409/416
(98 %)
6 diff
(98.6 %id)
CF145056 CNCAP(3)T-225 cell line, Prostate CCM2.a 564 to 1082 8 to 526       519/526
(98 %)
6 diff
(98.9 %id)
CF145142 CNCAP(3)T-225 cell line, Prostate CCM2.a 564 to 929 8 to 373       366/373
(98 %)
7 diff
(98.2 %id)
TI_154177234   CCM2.a 564 to 1103 80 to 619       540/541
(99 %)
7 diff
(98.8 %id)
TI_154177235   CCM2.a 564 to 1102 80 to 618   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
TI_154177330   CCM2.a 564 to 1159 80 to 680       601/682
(88 %)
18 diff
(97.4 %id)
TI_154177331   CCM2.a 564 to 1015 78 to 531       452/745
(60 %)
9 diff
(98.8 %id)
BF341957 brain, glioblastoma with EGFR amplification CCM2.a 868 to 1706 1 to 823   tiling clone,   823/833
(98 %)
25 diff
(97.0 %id)
DB263733 uterus CCM2.b 1 to 545 2 to 545   tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
DA179817 amygdala CCM2.b 437 to 958 2 to 523   tiling clone, capped   522/522
(100 %)
1 diff
(99.9 %id)
AK098005 thymus CCM2.b 456 to 2926 1 to 2471 F289C tiling clone, available from FLJ,   2471/2471
(100 %)
3 diff
(99.9 %id)
DB117380 thymus CCM2.b 457 to 1081 2 to 626   capped   625/625
(100 %)
2 diff
(99.7 %id)
AW805313 uterus CCM2.b 816 to 1139 336 to 8       329/336
(97 %)
0 diff
(100 %id)
NM_001029835.2   CCM2.b 1064 to 2944 1 to 1881 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1881/1881
(100 %)
0 diff
(100 %id)
DB119665 thymus CCM2.b 1065 to 1420 2 to 357   capped   356/356
(100 %)
0 diff
(100 %id)
DA932243 Spleen CCM2.b 1101 to 1669 2 to 570   capped   569/570
(99 %)
1 diff
(99.9 %id)
DA008187   CCM2.b 1103 to 1652 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA167632 amygdala CCM2.b 1103 to 1668 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA933954 Spleen CCM2.b 1103 to 1679 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA976657 synovial membrane tissue from rheumatioidarthritis CCM2.b 1103 to 1658 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA993413 synovial membrane tissue from rheumatioidarthritis CCM2.b 1103 to 1650 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB003197 breast, tumor tissue CCM2.b 1103 to 1644 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB123562 thymus CCM2.b 1103 to 1724 2 to 623   capped   622/622
(100 %)
0 diff
(100 %id)
DB134707 thymus CCM2.b 1103 to 1568 2 to 467   capped   466/466
(100 %)
0 diff
(100 %id)
DB147292 thymus CCM2.b 1103 to 1672 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB151654 thymus CCM2.b 1103 to 1668 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB128112 thymus CCM2.b 1105 to 1669 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA956095 Spleen CCM2.b 1115 to 1669 2 to 556   capped   555/561
(98 %)
2 diff
(99.7 %id)
BI225675 Burkitt lymphoma, lymph CCM2.b 1116 to 1585 1 to 471       471/472
(99 %)
5 diff
(99.0 %id)
BI226867 Burkitt lymphoma, lymph CCM2.b 1116 to 1713 1 to 598       598/600
(99 %)
4 diff
(99.4 %id)
BI225639 Burkitt lymphoma, lymph CCM2.b 1121 to 1629 7 to 515       509/515
(98 %)
3 diff
(99.5 %id)
DA671753   CCM2.b 1121 to 1687 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA675994   CCM2.b 1121 to 1705 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA979902 synovial membrane tissue from rheumatioidarthritis CCM2.b 1121 to 1693 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BU566902 mixed (pool of 40 RNAs) CCM2.b 1128 to 1274 1 to 147   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 147/176
(83 %)
5 diff
(97.2 %id)
BX363852   CCM2.b 1129 to 2038 1 to 909   tiling clone,   909/909
(100 %)
6 diff
(99.4 %id)
DA566103 heart CCM2.b 1131 to 1589 2 to 460   capped   459/459
(100 %)
0 diff
(100 %id)
DA676840   CCM2.b 1131 to 1706 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA815779   CCM2.b 1131 to 1688 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA827659 pericardium CCM2.b 1131 to 1673 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA963207 stomach CCM2.b 1131 to 1697 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB126831 thymus CCM2.b 1131 to 1705 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB147065 thymus CCM2.b 1131 to 1673 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB241878 stomach, tumor tissue CCM2.b 1131 to 1673 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BQ430893 embryonal carcinoma, cell line, testis CCM2.b 1133 to 2000 1 to 877       877/892
(98 %)
14 diff
(98.5 %id)
DA675618   CCM2.b 1133 to 1718 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA995138 synovial membrane tissue from rheumatioidarthritis CCM2.b 1134 to 1677 2 to 544   capped   543/545
(99 %)
4 diff
(99.3 %id)
BG256977 embryonal carcinoma, cell line, testis CCM2.b 1135 to 1734 1 to 617       615/1146
(53 %)
28 diff
(97.6 %id)
BE396394 Burkitt lymphoma, lymph CCM2.b 1136 to 1922 1 to 785       785/818
(95 %)
10 diff
(98.8 %id)
BE560344 Burkitt lymphoma, lymph CCM2.b 1136 to 1932 1 to 796       794/924
(85 %)
13 diff
(98.6 %id)
BE559652 Burkitt lymphoma, lymph CCM2.b 1136 to 1864 1 to 730       730/739
(98 %)
26 diff
(96.5 %id)
BE559587 Burkitt lymphoma, lymph CCM2.b 1136 to 1943 1 to 804       804/1080
(74 %)
29 diff
(97.4 %id)
BE560410 Burkitt lymphoma, lymph CCM2.b 1136 to 1937 1 to 791       791/1032
(76 %)
30 diff
(97.1 %id)
DA671192   CCM2.b 1136 to 1725 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA674918   CCM2.b 1136 to 1715 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BI906204 leukocyte CCM2.b 1145 to 1525 1 to 387       387/464
(83 %)
6 diff
(98.8 %id)
TI_57232080   CCM2.b 1145 to 1525 34 to 420       387/464
(83 %)
6 diff
(98.8 %id)
BM920295 pooled pancreas and spleen CCM2.b 1147 to 2003 18 to 873       856/1076
(79 %)
22 diff
(98.0 %id)
BG341818 B-cells, primary B-cells from tonsils (cell line) CCM2.b 1149 to 1923 1 to 768       768/887
(86 %)
22 diff
(97.6 %id)
BQ053014 blood, natural killer cells, cell line CCM2.b 1198 to 1939 1 to 751       751/1151
(65 %)
26 diff
(97.8 %id)
AA455323 germinal center B cell CCM2.b 1210 to 1650 1 to 441     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
BX363851   CCM2.b 2252 to 2879 636 to 9       628/973
(64 %)
0 diff
(100 %id)
DB343745 thymus CCM2.b 2364 to 2926 568 to 1       568/568
(100 %)
5 diff
(99.2 %id)
AI918169 anaplastic oligodendroglioma, brain CCM2.b 2773 to 2914 143 to 2       142/143
(99 %)
0 diff
(100 %id)
AA454941 germinal center B cell CCM2.b 2814 to 2926 147 to 35   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 113/113
(100 %)
0 diff
(100 %id)
GD137676   CCM2.b 2863 to 2926 1 to 64   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 64/64
(100 %)
2 diff
(96.9 %id)
GD138304   CCM2.b 2866 to 2942 1 to 77   tiling clone,   77/89
(86 %)
2 diff
(97.8 %id)
GD138305   CCM2.b 2866 to 2918 1 to 53   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 53/53
(100 %)
2 diff
(96.3 %id)
AF370392   CCM2.c 1 to 1866 1 to 1866 D440A tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1866/1867
(99 %)
14 diff
(99.3 %id)
NM_031443.3   CCM2.c 1 to 1893 1 to 1893 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1893/1893
(100 %)
0 diff
(100 %id)
TI_57239776   CCM2.c 17 to 875 27 to 884       858/885
(96 %)
12 diff
(98.7 %id)
BI916251 brain CCM2.c 20 to 875 1 to 855       855/856
(99 %)
6 diff
(99.3 %id)
BX340504   CCM2.c 22 to 1055 16 to 1042       1027/1046
(98 %)
21 diff
(98.0 %id)
BX336146 Placenta Cot 25-normalized CCM2.c 26 to 871 1 to 855       853/855
(99 %)
13 diff
(98.5 %id)
BQ958961 carcinoma, cell line, Prostate CCM2.c 28 to 891 32 to 899       868/948
(91 %)
23 diff
(97.6 %id)
BQ919314 carcinoma, cell line, Prostate CCM2.c 34 to 949 1 to 923       923/937
(98 %)
28 diff
(97.1 %id)
BQ928880 carcinoma, cell line, Prostate CCM2.c 34 to 884 1 to 864       864/949
(91 %)
38 diff
(96.0 %id)
CD518565 White Matter CCM2.c 35 to 876 27 to 873       847/919
(92 %)
15 diff
(98.4 %id)
CR599466 Placenta Cot 25-normalized CCM2.c 41 to 1822 1 to 1782 exact     1782/1782
(100 %)
0 diff
(100 %id)
BM800084 leiomyosarcoma, uterus CCM2.c 43 to 882 52 to 904       853/1134
(75 %)
39 diff
(96.6 %id)
BX337677 Placenta Cot 25-normalized CCM2.c 50 to 998 8 to 956   fully sequenced,   949/956
(99 %)
7 diff
(99.3 %id)
BQ894632 dorsal root ganglia CCM2.c 53 to 949 1 to 901       901/913
(98 %)
15 diff
(98.4 %id)
CR602233 Neuroblastoma Cot 25-normalized CCM2.c 54 to 1847 1 to 1794 exact     1794/1794
(100 %)
0 diff
(100 %id)
BX394575 Neuroblastoma Cot 25-normalized CCM2.c 54 to 939 1 to 888   fully sequenced,   888/888
(100 %)
3 diff
(99.7 %id)
BI757283 brain CCM2.c 54 to 925 1 to 873       873/874
(99 %)
12 diff
(98.7 %id)
TI_57221590   CCM2.c 54 to 925 67 to 939       873/940
(92 %)
18 diff
(98.1 %id)
BG748466 eye, normal pigmented retinal epithelium CCM2.c 55 to 925 1 to 877       877/880
(99 %)
16 diff
(98.2 %id)
BG749630 eye, normal pigmented retinal epithelium CCM2.c 55 to 757 1 to 711       711/777
(91 %)
13 diff
(98.4 %id)
BF969290 adrenal cortex carcinoma, cell line, adrenal gland CCM2.c 59 to 844 1 to 779       779/805
(96 %)
9 diff
(98.9 %id)
BU535696 adenocarcinoma, cell line, breast CCM2.c 62 to 757 1 to 697       697/938
(74 %)
10 diff
(99.0 %id)
BF311330 brain, neuroblastoma CCM2.c 65 to 809 1 to 743       743/914
(81 %)
18 diff
(98.1 %id)
BF312784 brain, neuroblastoma CCM2.c 65 to 870 1 to 794       794/904
(87 %)
29 diff
(96.8 %id)
BF312261 brain, neuroblastoma CCM2.c 65 to 813 1 to 745       747/780
(95 %)
15 diff
(98.1 %id)
BF316925 brain, neuroblastoma CCM2.c 65 to 727 1 to 655       655/789
(83 %)
18 diff
(97.8 %id)
BI195991 brain, neuroblastoma CCM2.c 65 to 661 1 to 601       601/604
(99 %)
7 diff
(98.9 %id)
BC004903 Brain, neuroblastoma CCM2.c 66 to 1875 1 to 1810 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1810/1810
(100 %)
0 diff
(100 %id)
BC008859 Brain, neuroblastoma CCM2.c 66 to 1875 1 to 1810   available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1810/1810
(100 %)
0 diff
(100 %id)
CR607004 B cells (Ramos cell line) Cot 25-normalized CCM2.c 66 to 1841 1 to 1776 exact     1776/1776
(100 %)
0 diff
(100 %id)
BX342756   CCM2.c 66 to 980 1 to 916   fully sequenced,   916/916
(100 %)
2 diff
(99.8 %id)
CA397994 eye, RPE/choroid CCM2.c 69 to 656 1 to 588     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 588/588
(100 %)
0 diff
(100 %id)
BG421563 Kidney, renal cell adenocarcinoma CCM2.c 71 to 717 1 to 682       680/931
(73 %)
99 diff
(89.4 %id)
BQ669183 epidermoid carcinoma, cell line, salivary gland CCM2.c 71 to 891 1 to 831       831/867
(95 %)
14 diff
(98.4 %id)
BQ893781 epidermoid carcinoma, cell line, salivary gland CCM2.c 71 to 840 1 to 776       776/905
(85 %)
18 diff
(98.1 %id)
BQ669946 epidermoid carcinoma, cell line, salivary gland CCM2.c 71 to 675 1 to 606       606/998
(60 %)
8 diff
(99.2 %id)
BC016832 Kidney, renal cell adenocarcinoma CCM2.c 72 to 1870 1 to 1799 exact available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1799/1799
(100 %)
0 diff
(100 %id)
BQ440101 melanotic melanoma, skin CCM2.c 79 to 881 1 to 810       810/882
(91 %)
6 diff
(99.4 %id)
TI_43960385   CCM2.c 81 to 888 66 to 882       817/986
(82 %)
30 diff
(97.0 %id)
BI489804 pooled brain, lung, testis CCM2.c 82 to 888 1 to 816       816/920
(88 %)
24 diff
(97.4 %id)
BI818798 pooled brain, lung, testis CCM2.c 83 to 952 1 to 876       874/918
(95 %)
22 diff
(97.7 %id)
TI_57200085   CCM2.c 83 to 952 36 to 911       874/953
(91 %)
28 diff
(97.1 %id)
BQ711269 Spleen CCM2.c 84 to 949 1 to 867       867/915
(94 %)
5 diff
(99.5 %id)
BE313340 brain, neuroblastoma CCM2.c 86 to 717 1 to 633       633/690
(91 %)
14 diff
(98.0 %id)
BG760834 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 740 1 to 655       655/660
(99 %)
2 diff
(99.7 %id)
BG761498 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 711 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BG770526 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 891 1 to 808       808/875
(92 %)
14 diff
(98.4 %id)
BG764884 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 802 1 to 722       722/818
(88 %)
13 diff
(98.5 %id)
BG767414 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 720 1 to 631       631/631
(100 %)
6 diff
(99.1 %id)
BG768653 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 952 1 to 863       865/891
(97 %)
23 diff
(97.5 %id)
BG769171 melanotic melanoma, high MDR (cell line), skin CCM2.c 86 to 922 1 to 842       842/846
(99 %)
24 diff
(97.2 %id)
BE906639 epithelioid carcinoma, Pancreas CCM2.c 87 to 797 1 to 710       710/711
(99 %)
3 diff
(99.6 %id)
BG338071 leiomyosarcoma cell line, uterus CCM2.c 96 to 889 1 to 801       801/946
(84 %)
12 diff
(98.8 %id)
TI_57187928   CCM2.c 96 to 853 52 to 810       759/760
(99 %)
10 diff
(98.7 %id)
BI860372 breast, mammary adenocarcinoma, cell line CCM2.c 98 to 853 1 to 757       757/758
(99 %)
10 diff
(98.7 %id)
CR999549 T-Lymphocytes CCM2.c 105 to 922 1 to 824       824/826
(99 %)
8 diff
(99.1 %id)
BE794162 lung, small cell carcinoma CCM2.c 106 to 872 1 to 767       767/1059
(72 %)
11 diff
(99.0 %id)
CV026094 mixed CCM2.c 147 to 753 1 to 607       607/613
(99 %)
1 diff
(99.9 %id)
TI_1948129738   CCM2.c 147 to 756 129 to 747       619/1211
(51 %)
23 diff
(98.2 %id)
TI_1948129739   CCM2.c 147 to 894 124 to 872       749/1425
(52 %)
15 diff
(99.0 %id)
TI_1948130082   CCM2.c 147 to 757 129 to 740       612/1173
(52 %)
28 diff
(97.7 %id)
TI_1948130083   CCM2.c 147 to 952 124 to 928       805/1316
(61 %)
21 diff
(98.5 %id)
TI_1948130423   CCM2.c 147 to 818 126 to 802       677/1132
(59 %)
27 diff
(97.7 %id)
TI_1948130424   CCM2.c 147 to 949 121 to 921       801/1300
(61 %)
25 diff
(98.1 %id)
TI_1948129391   CCM2.c 148 to 757 129 to 739       611/1451
(42 %)
14 diff
(99.1 %id)
BX394574 Neuroblastoma Cot 25-normalized CCM2.c 909 to 1847 933 to 1   fully sequenced,   933/933
(100 %)
23 diff
(97.6 %id)
BX342755   CCM2.c 919 to 1841 923 to 1   fully sequenced,   923/923
(100 %)
7 diff
(99.3 %id)
BX336145 Placenta Cot 25-normalized CCM2.c 950 to 1808 932 to 12       504/932
(54 %)
20 diff
(97.9 %id)
BX337676 Placenta Cot 25-normalized CCM2.c 968 to 1822 854 to 1   fully sequenced,   854/854
(100 %)
22 diff
(97.5 %id)
BX373873   CCM2.c 1200 to 1848 652 to 4       649/775
(83 %)
0 diff
(100 %id)
CA397993 eye, RPE/choroid CCM2.c 1397 to 1889 509 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 493/493
(100 %)
1 diff
(99.8 %id)
CR618287 fetal liver CCM2.d 1 to 1686 1 to 1686 exact tiling clone,   1686/1686
(100 %)
0 diff
(100 %id)
BX444094 fetal liver, Liver CCM2.d 23 to 907 20 to 905       886/905
(97 %)
11 diff
(98.8 %id)
NM_001167934.1   CCM2.d 23 to 1741 1 to 1719 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1719/1719
(100 %)
0 diff
(100 %id)
BX334285 Placenta Cot 25-normalized CCM2.d 29 to 907 1 to 884       884/884
(100 %)
35 diff
(96.1 %id)
CD557939 testis CCM2.d 29 to 824 24 to 826       803/901
(89 %)
15 diff
(98.4 %id)
BX345945   CCM2.d 59 to 889 1 to 833       833/833
(100 %)
20 diff
(97.6 %id)
BI761499 pooled colon, kidney, stomach CCM2.d 65 to 798 1 to 733       733/760
(96 %)
15 diff
(98.1 %id)
TI_57149296   CCM2.d 65 to 798 30 to 762       733/789
(92 %)
21 diff
(97.4 %id)
DB493395 hypothalamus CCM2.d 68 to 559 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
BM563951 brain, medulla CCM2.d 69 to 792 1 to 725       725/1117
(64 %)
21 diff
(98.2 %id)
CN399566 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CCM2.d 72 to 436 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
CV571060 cornea, eye CCM2.d 86 to 698 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BI518825 leukocyte CCM2.d 88 to 739 1 to 683       681/911
(74 %)
47 diff
(94.9 %id)
BM559552 brain, medulla CCM2.d 88 to 1061 1 to 980       980/1061
(92 %)
21 diff
(98.1 %id)
BM922546 leukocyte CCM2.d 88 to 1059 14 to 991       978/1129
(86 %)
23 diff
(98.0 %id)
TI_44459238   CCM2.d 88 to 797 65 to 812       746/975
(76 %)
63 diff
(93.6 %id)
BX383605   CCM2.d 122 to 608 1 to 489       489/551
(88 %)
13 diff
(97.7 %id)
CR618943 Placenta Cot 25-normalized CCM2.d 161 to 1680 1 to 1520 exact     1520/1520
(100 %)
0 diff
(100 %id)
BX337466 Placenta Cot 25-normalized CCM2.d 161 to 1202 1 to 1036       1036/1040
(99 %)
14 diff
(98.7 %id)
BX365022 Placenta Cot 25-normalized CCM2.d 161 to 1136 1 to 971       971/1030
(94 %)
13 diff
(98.8 %id)
BI519480 leukocyte CCM2.d 855 to 1429 590 to 1       598/590
(101 %)
16 diff
(97.3 %id)
TI_44459239   CCM2.d 855 to 1636 797 to 2       796/797
(99 %)
3 diff
(99.7 %id)
BX334284 Placenta Cot 25-normalized CCM2.d 910 to 1708 799 to 1   tiling clone,   799/1040
(76 %)
40 diff
(96.2 %id)
BX345944   CCM2.d 1048 to 1674 629 to 1       629/766
(82 %)
41 diff
(94.7 %id)
NM_001167935.1   CCM2.e 1 to 1620 1 to 1620 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1620/1620
(100 %)
0 diff
(100 %id)
BX384065   CCM2.e 42 to 819 1 to 779   fully sequenced,   779/779
(100 %)
5 diff
(99.4 %id)
CR604060 HeLa cells Cot 25-normalized CCM2.e 44 to 1572 1 to 1529 exact tiling clone,   1529/1529
(100 %)
0 diff
(100 %id)
BI083896 epidermoid carcinoma, cell line, salivary gland CCM2.e 69 to 590 1 to 539       539/539
(100 %)
26 diff
(95.2 %id)
BG421932 Kidney, renal cell adenocarcinoma CCM2.e 72 to 748 1 to 676       676/980
(68 %)
8 diff
(99.2 %id)
BE208386 Kidney, renal cell adenocarcinoma CCM2.e 110 to 534 1 to 425       425/425
(100 %)
26 diff
(93.9 %id)
AA459151 germinal center B cell CCM2.e 376 to 858 1 to 483       483/487
(99 %)
7 diff
(98.6 %id)
W48794 senescent fibroblast CCM2.e 530 to 994 1 to 470       470/471
(99 %)
11 diff
(97.7 %id)
AJ713352 bone marrow CCM2.e 590 to 1046 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
BI084565 epidermoid carcinoma, cell line, salivary gland CCM2.e 725 to 1552 833 to 1       831/835
(99 %)
10 diff
(98.9 %id)
BX384064   CCM2.e 758 to 1572 827 to 1   fully sequenced,   827/827
(100 %)
2 diff
(99.8 %id)
BE301145 Kidney, renal cell adenocarcinoma CCM2.e 1177 to 1599 425 to 3       423/425
(99 %)
0 diff
(100 %id)
AA458937 germinal center B cell CCM2.e 1184 to 1602 418 to 1   tiling clone,   418/418
(100 %)
3 diff
(99.3 %id)
W49620 senescent fibroblast CCM2.e 1187 to 1602 418 to 1       418/420
(99 %)
9 diff
(97.9 %id)
TI_57177905   CCM2.f 1 to 884 71 to 956   tiling clone,   886/956
(92 %)
18 diff
(98.2 %id)
BI766123 pooled lung and spleen CCM2.f 2 to 884 1 to 885   tiling clone,   885/885
(100 %)
13 diff
(98.6 %id)
BG179361 adenocarcinoma, cell line, Prostate CCM2.f 25 to 789 1 to 763   tiling clone,   763/763
(100 %)
20 diff
(97.4 %id)
BQ957073 carcinoma, cell line, Prostate CCM2.g 1 to 701 19 to 728   tiling clone,   710/1062
(66 %)
34 diff
(96.8 %id)
AA676879 whole brain CCM2.g 652 to 961 314 to 5   tiling clone,   310/314
(98 %)
0 diff
(100 %id)
AW630545 2 pooled high-grade transitional celltumors, genitourinary tract CCM2.h 1 to 401 14 to 416   tiling clone, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 403/416
(96 %)
10 diff
(97.6 %id)
CR621631 fetal liver CCM2.h 12 to 1730 1 to 1719 exact tiling clone,   1719/1719
(100 %)
0 diff
(100 %id)
BX462850 fetal liver, Liver CCM2.h 12 to 912 1 to 902 exact fully sequenced,   902/902
(100 %)
1 diff
(99.9 %id)
CR618439 Placenta Cot 25-normalized CCM2.h 655 to 1755 1 to 1101       1101/1101
(100 %)
0 diff
(100 %id)
BX379131 Placenta Cot 25-normalized CCM2.h 655 to 1741 1 to 1074   fully sequenced,   1074/1074
(100 %)
24 diff
(97.8 %id)
BX379130 Placenta Cot 25-normalized CCM2.h 811 to 1725 910 to 1   fully sequenced,   910/910
(100 %)
6 diff
(99.4 %id)
BX462849 fetal liver, Liver CCM2.h 883 to 1730 847 to 1   fully sequenced,   847/847
(100 %)
19 diff
(97.8 %id)
AW627509 2 pooled high-grade transitional celltumors, genitourinary tract CCM2.h 1618 to 1781 174 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 164/164
(100 %)
0 diff
(100 %id)
DC406701 thymus CCM2.i 1 to 513 2 to 514       514/514
(100 %)
2 diff
(99.7 %id)
DC407481 thymus CCM2.i 1 to 548 2 to 549   tiling clone,   549/549
(100 %)
1 diff
(99.9 %id)
AK303216 thymus CCM2.i 2 to 1460 1 to 1459 exact tiling clone,   1459/1459
(100 %)
1 diff
(100.0 %id)
DC340282 thalamus CCM2.i 2 to 573 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DC404993 thymus CCM2.i 2 to 565 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
DC406681 thymus CCM2.i 3 to 579 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DC390778 Spleen CCM2.i 11 to 565 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
DC408552 thymus CCM2.i 12 to 557 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BF894867 marrow CCM2.i 999 to 1206 1 to 208   tiling clone,   208/208
(100 %)
0 diff
(100 %id)
BU838664 epidermoid carcinoma, cell line, salivary gland CCM2.j 1 to 580 1 to 580   tiling clone,   580/973
(59 %)
13 diff
(98.7 %id)
BQ669656 epidermoid carcinoma, cell line, salivary gland CCM2.j 1 to 875 1 to 894 H5P T6L V7W V8C L9C ... tiling clone,   894/939
(95 %)
43 diff
(95.5 %id)
BX439329 placenta CCM2.k 1 to 1015 1 to 1004 T237Q A238Q R239D P240H S241Q ... tiling clone, fully sequenced,   1004/1004
(100 %)
13 diff
(98.8 %id)
BX434233 placenta CCM2.k 985 to 1706 735 to 4   tiling clone, fully sequenced,   732/735
(99 %)
15 diff
(98.0 %id)
BQ072817 leukocyte CCM2.l 1 to 674 20 to 693 S241K tiling clone,   936/1080
(86 %)
39 diff
(96.4 %id)
BG722235 testis CCM2.m 1 to 788 1 to 793 H184Q H185Q T213N L214S A215C ... tiling clone,   793/796
(99 %)
11 diff
(98.7 %id)
AA326735 brain, cerebellum CCM2.m 362 to 727 1 to 368   tiling clone,   368/368
(100 %)
2 diff
(99.5 %id)
DA952411 Spleen CCM2.n 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
BF891778 marrow CCM2.n 429 to 696 13 to 280   tiling clone,   268/280
(95 %)
6 diff
(97.9 %id)
TI_57219351   CCM2.o 1 to 667 22 to 699 K30E T104N H107K H108Q H112N ... tiling clone,   678/710
(95 %)
36 diff
(95.0 %id)
BP204297 coronary artery CCM2.p 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
DB154227 thymus CCM2.q 1 to 592 2 to 593 V74I tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
BI907152 leukocyte CCM2.r 1 to 736 1 to 737 E44A D45G I46Y I47H L48P ... tiling clone,   737/738
(99 %)
5 diff
(99.4 %id)
TI_57234126   CCM2.r 1 to 736 33 to 769 E44A D45G I46Y I47H L48P ...     737/770
(95 %)
10 diff
(98.8 %id)
AK298671   CCM2.s 1 to 1061 1 to 1061 exact tiling clone,   1061/1061
(100 %)
1 diff
(100.0 %id)
DC428772   CCM2.s 1 to 584 1 to 584 exact     584/584
(100 %)
0 diff
(100 %id)
TI_57233150   CCM2.t 1 to 753 36 to 789 exact tiling clone,   905/938
(96 %)
23 diff
(97.6 %id)
BI906707 leukocyte CCM2.t 1 to 712 2 to 714 exact tiling clone,   714/714
(100 %)
2 diff
(99.8 %id)
BE619396 large cell carcinoma, lung CCM2.u 1 to 791 1 to 793 H74Q H114T S115A K116R T117P ... tiling clone,   793/1025
(77 %)
20 diff
(98.1 %id)
CB989262 Human Placenta, placenta CCM2.va 1 to 516 27 to 549   tiling clone,   523/936
(55 %)
24 diff
(97.5 %id)
BI197336 brain, neuroblastoma CCM2.va 11 to 563 1 to 571   tiling clone,   571/996
(57 %)
27 diff
(97.3 %id)
BG324675 Kidney, renal cell adenocarcinoma CCM2.va 18 to 481 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
BG423836 Kidney, renal cell adenocarcinoma CCM2.va 18 to 587 1 to 577 K26Q E38D I63L T106H Q107S ... tiling clone,   577/1142
(50 %)
20 diff
(98.3 %id)
BE313684 brain, neuroblastoma CCM2.va 31 to 516 1 to 486   tiling clone,   486/487
(99 %)
1 diff
(99.8 %id)
TI_1948129390   CCM2.va 93 to 561 128 to 595   tiling clone,   468/1121
(41 %)
12 diff
(99.0 %id)
TI_44159373   CCM2.vb 1 to 708 80 to 787 exact tiling clone,   708/791
(89 %)
18 diff
(97.8 %id)
BI523801 pooled lung and spleen CCM2.vb 6 to 708 1 to 703 exact     703/707
(99 %)
1 diff
(99.9 %id)
AK303534 thymus CCM2.vc 1 to 1137 2 to 1138 exact tiling clone,   1138/1138
(100 %)
6 diff
(99.5 %id)
DC409894 thymus CCM2.vc 1 to 572 2 to 573 exact     573/573
(100 %)
2 diff
(99.7 %id)
AA485108 germinal center B cell CCM2.vc 618 to 925 304 to 1     Submitted on the opposite strand 304/304
(100 %)
3 diff
(99.1 %id)
BF846408 lung_normal CCM2.vc 619 to 1043 429 to 2   tiling clone, Submitted on the opposite strand 428/429
(99 %)
0 diff
(100 %id)
CV364065 lung_normal CCM2.vc 718 to 1034 353 to 30   tiling clone, Submitted on the opposite strand 324/358
(90 %)
0 diff
(100 %id)
CX872822 embryonic stem CCM2.vd 1 to 816 1 to 816 exact tiling clone,   816/816
(100 %)
1 diff
(99.9 %id)
BG912178 anaplastic oligodendroglioma with 1p/19qloss, brain CCM2.vd 49 to 846 1 to 800 exact tiling clone,   800/801
(99 %)
7 diff
(99.2 %id)
DA983503 synovial membrane tissue from rheumatioidarthritis CCM2.ve 1 to 541 2 to 542 W10R tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
DB476849 hippocampus CCM2.vf 1 to 499 1 to 499 P16Q tiling clone,   499/499
(100 %)
3 diff
(99.4 %id)
TI_154160633   CCM2.vg 1 to 100 83 to 182 F65V tiling clone,   649/691
(93 %)
20 diff
(97.2 %id)
BE868463 adenocarcinoma, colon CCM2.vh 1 to 656 1 to 652 A17R I33M F41L L42P G44R ... tiling clone, available from MGC,   652/653
(99 %)
22 diff
(96.7 %id)
AA359801 lung CCM2.vh 278 to 543 1 to 269   tiling clone,   269/269
(100 %)
3 diff
(98.9 %id)
DA363540 subthalamic nucleus CCM2.vi 1 to 548 2 to 550 exact tiling clone, capped   549/549
(100 %)
3 diff
(99.5 %id)
BG385641 adenocarcinoma cell line, colon CCM2.vj 1 to 552 15 to 564   tiling clone,   558/564
(98 %)
8 diff
(98.6 %id)
BX641167 human salivary gland CCM2.vj 522 to 5823 1 to 5303   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 5303/5303
(100 %)
5 diff
(100.0 %id)
BU859289 ovary, teratocarcinoma, cell line CCM2.vj 1116 to 1976 1 to 873       873/900
(97 %)
18 diff
(98.0 %id)
BX404704 thymus CCM2.vj 1685 to 2805 1 to 1111       1111/1120
(99 %)
26 diff
(97.7 %id)
BX404837 thymus CCM2.vj 1685 to 2797 1 to 1116   tiling clone,   1116/1116
(100 %)
19 diff
(98.3 %id)
BX436554 thymus CCM2.vj 1685 to 2705 1 to 1004       1004/1009
(99 %)
20 diff
(98.1 %id)
DB133315 thymus CCM2.vj 1845 to 2422 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB152042 thymus CCM2.vj 1860 to 2464 2 to 607   capped   606/606
(100 %)
3 diff
(99.6 %id)
DB152958 thymus CCM2.vj 1948 to 2530 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
AA485109 germinal center B cell CCM2.vj 2032 to 2385 1 to 353     Submitted on the opposite strand 353/353
(100 %)
1 diff
(99.8 %id)
DB147189 thymus CCM2.vj 2193 to 2778 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BF743446 breast CCM2.vj 2203 to 2542 344 to 2     Submitted on the opposite strand 343/344
(99 %)
0 diff
(100 %id)
DB145336 thymus CCM2.vj 2213 to 2729 2 to 519   capped   518/518
(100 %)
3 diff
(99.5 %id)
AA381875   CCM2.vj 2553 to 2852 1 to 300       300/305
(98 %)
2 diff
(99.4 %id)
AA381933   CCM2.vj 2553 to 2852 1 to 301       301/306
(98 %)
4 diff
(98.7 %id)
AA382012   CCM2.vj 2553 to 2833 1 to 284       284/290
(97 %)
7 diff
(97.6 %id)
AW963576   CCM2.vj 2554 to 3208 1 to 647       647/696
(92 %)
17 diff
(97.6 %id)
CV814690 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CCM2.vj 2767 to 3512 1 to 751       751/891
(84 %)
28 diff
(96.9 %id)
BF899903 marrow CCM2.vj 2981 to 3135 166 to 11     Submitted on the opposite strand 156/172
(90 %)
0 diff
(100 %id)
BE715630 head_neck CCM2.vj 3230 to 3637 412 to 1   tiling clone,   412/428
(96 %)
11 diff
(97.5 %id)
DA960270 Spleen CCM2.vj 3300 to 3864 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DB127440 thymus CCM2.vj 3728 to 4273 2 to 547   tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
DB122046 thymus CCM2.vj 3770 to 4324 2 to 557   capped   556/556
(100 %)
5 diff
(99.2 %id)
DB344782 thymus CCM2.vj 5254 to 5815 562 to 1       562/562
(100 %)
2 diff
(99.7 %id)
DA240759 brain CCM2.vk 1 to 594 2 to 595   tiling clone, capped   594/594
(100 %)
2 diff
(99.7 %id)
DB155803 thymus CCM2.vk 227 to 711 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
AK124060 synovial membrane tissue from rheumatioidarthritis CCM2.vk 377 to 2426 1 to 2050   tiling clone, available from FLJ,   2050/2050
(100 %)
2 diff
(100.0 %id)
DA976933 synovial membrane tissue from rheumatioidarthritis CCM2.vk 378 to 917 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB219057 trachea CCM2.vk 696 to 1235 2 to 541   tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
DB334850 synovial membrane tissue from rheumatioidarthritis CCM2.vk 1896 to 2426 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
R11906 whole brain CCM2.vl-u 1 to 522 1 to 519   tiling clone,   519/523
(99 %)
8 diff
(98.5 %id)
TI_151783724   CCM2.vl-u 373 to 1127 74 to 818   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 745/917
(81 %)
35 diff
(96.2 %id)
BM823994 Ascites, stomach CCM2.vl-u 1016 to 1389 1 to 375   tiling clone,   375/375
(100 %)
6 diff
(98.4 %id)
AW954264   CCM2.vl-u 1154 to 1866 1 to 711   tiling clone,   711/713
(99 %)
14 diff
(98.1 %id)
TI_151756592   CCM2.vl-u 1312 to 2081 845 to 83   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 763/878
(86 %)
25 diff
(97.2 %id)
R39098 whole brain CCM2.vl-u 1632 to 2088 461 to 2   tiling clone,   460/464
(99 %)
0 diff
(100 %id)
BX460017 brain, fetal brain CCM2.vm 1 to 983 1 to 982 exact tiling clone,   982/982
(100 %)
4 diff
(99.6 %id)
BM705833 eye, lens CCM2.vm 871 to 1308 1 to 438   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 438/438
(100 %)
0 diff
(100 %id)
BM667814 eye, lens CCM2.vm 1278 to 1817 558 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 540/540
(100 %)
1 diff
(99.9 %id)
BX412745 brain, fetal brain CCM2.vm 1395 to 1828 431 to 1   tiling clone,   431/481
(89 %)
33 diff
(93.2 %id)
NR_030770.1   CCM2.vn 1 to 1821 9 to 1829   RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1829/1829
(100 %)
0 diff
(100 %id)
DA280015 corpus callosum CCM2.vn 1 to 562 8 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
CN333898 embryonic stem cells, cell lines H1, H7, andH9 CCM2.vn 1 to 534 1 to 534       534/534
(100 %)
4 diff
(99.3 %id)
DA897051 skeletal muscle CCM2.vn 1 to 546 2 to 547   capped   546/551
(99 %)
4 diff
(99.3 %id)
CR600732 Neuroblastoma Cot 25-normalized CCM2.vn 12 to 1704 1 to 1693       1693/1693
(100 %)
0 diff
(100 %id)
BE791970 lung, small cell carcinoma CCM2.vn 107 to 850 1 to 742       744/743
(100 %)
9 diff
(98.8 %id)
CN333901 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CCM2.vn 111 to 365 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BP254066 Kidney CCM2.vn 128 to 711 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DA141979 alzheimer cortex CCM2.vn 131 to 673 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BP270664 small intestine CCM2.vn 155 to 734 1 to 581       581/584
(99 %)
7 diff
(98.9 %id)
TI_154181431   CCM2.vn 159 to 1130 80 to 1044       965/966
(99 %)
25 diff
(97.5 %id)
CF140231 CNCAP(3)T-225 cell line, Prostate CCM2.vn 162 to 599 1 to 438       438/438
(100 %)
6 diff
(98.7 %id)
TI_154180326   CCM2.vn 162 to 977 69 to 883       815/816
(99 %)
10 diff
(98.8 %id)
BQ671104 epidermoid carcinoma, cell line, salivary gland CCM2.vn 163 to 999 1 to 839       839/934
(89 %)
15 diff
(98.4 %id)
BQ673425 epidermoid carcinoma, cell line, salivary gland CCM2.vn 163 to 984 1 to 832       832/871
(95 %)
29 diff
(96.7 %id)
CF121302 CNCAP(3)T-225 cell line, Prostate CCM2.vn 163 to 833 9 to 680       672/680
(98 %)
8 diff
(98.9 %id)
CF122016 CNCAP(3)T-225 cell line, Prostate CCM2.vn 163 to 796 11 to 644       634/644
(98 %)
7 diff
(99.0 %id)
BP255662 Kidney CCM2.vn 164 to 745 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CN333903 embryonic stem cells, cell lines H1, H7, andH9 CCM2.vn 165 to 671 1 to 509       509/509
(100 %)
5 diff
(99.1 %id)
TI_154170594   CCM2.vn 168 to 685 77 to 594       518/897
(57 %)
10 diff
(98.9 %id)
BG751258 eye, normal pigmented retinal epithelium CCM2.vn 185 to 995 1 to 813       813/999
(81 %)
17 diff
(98.3 %id)
AK025807   CCM2.vn 214 to 1803 1 to 1589 R76A G77A I78S I79S T80L ... available from FLJ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1589/1589
(100 %)
4 diff
(99.8 %id)
BP251939 Kidney CCM2.vn 214 to 783 1 to 570       570/576
(98 %)
14 diff
(97.6 %id)
CB105660 Liver CCM2.vn 215 to 621 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
BG326028 Kidney, renal cell adenocarcinoma CCM2.vn 217 to 918 1 to 702       702/702
(100 %)
8 diff
(98.9 %id)
BM049257 carcinoma, cell line, Prostate CCM2.vn 217 to 931 1 to 719       719/721
(99 %)
13 diff
(98.2 %id)
BF094235 uterus_tumor CCM2.vn 219 to 356 18 to 155       138/155
(89 %)
8 diff
(94.9 %id)
BI194161 epithelioid carcinoma cell line, Pancreas CCM2.vn 232 to 999 1 to 777       777/1018
(76 %)
24 diff
(97.7 %id)
BP300650   CCM2.vn 275 to 819 1 to 544       544/597
(91 %)
8 diff
(98.7 %id)
AA446831   CCM2.vn 277 to 462 98 to 282       185/282
(65 %)
7 diff
(97.6 %id)
BG282458 melanotic melanoma, skin CCM2.vn 277 to 1136 1 to 859       859/905
(94 %)
30 diff
(96.7 %id)
CB140698 Liver CCM2.vn 277 to 744 11 to 479       469/479
(97 %)
8 diff
(98.4 %id)
DB494124 hypothalamus CCM2.vn 278 to 797 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BI261697 lymph, lymphoma, cell line CCM2.vn 279 to 1104 1 to 831       831/835
(99 %)
27 diff
(96.8 %id)
BI822880 pooled brain, lung, testis CCM2.vn 279 to 1067 81 to 872       792/873
(90 %)
25 diff
(97.2 %id)
TI_57202077   CCM2.vn 279 to 1067 113 to 904       792/905
(87 %)
25 diff
(97.3 %id)
BQ056679 lymph, lymphoma, cell line CCM2.vn 281 to 1139 1 to 862       862/1006
(85 %)
20 diff
(98.1 %id)
CF134588 CNCAP(3)T-225 cell line, Prostate CCM2.vn 306 to 846 7 to 547       541/547
(98 %)
6 diff
(99.0 %id)
TI_154162661   CCM2.vn 306 to 995 78 to 768       691/1145
(60 %)
12 diff
(99.0 %id)
BQ050503 leiomyosarcoma, uterus CCM2.vn 321 to 1141 1 to 822       822/1057
(77 %)
7 diff
(99.4 %id)
DT219935 brain CCM2.vn 330 to 919 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
CN333902 embryonic stem cells, DMSO-treated H9 cellline CCM2.vn 336 to 843 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BG332379 large cell carcinoma, lung CCM2.vn 340 to 942 26 to 619       561/954
(58 %)
55 diff
(94.3 %id)
BU859132 ovary, teratocarcinoma, cell line CCM2.vn 349 to 1187 1 to 848       848/907
(93 %)
13 diff
(98.6 %id)
AA354204   CCM2.vn 351 to 658 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BF345793 anaplastic oligodendroglioma with 1p/19qloss, brain CCM2.vn 369 to 1019 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BP296361   CCM2.vn 402 to 980 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
DA090479 cerebellum CCM2.vn 411 to 989 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BI195583 brain, neuroblastoma CCM2.vn 413 to 1067 1 to 654       654/654
(100 %)
2 diff
(99.7 %id)
BE394832 endometrium, adenocarcinoma cell line, uterus CCM2.vn 420 to 1133 1 to 710       710/751
(94 %)
18 diff
(97.7 %id)
BX280968 pooled lung and spleen CCM2.vn 448 to 967 25 to 545       521/545
(95 %)
6 diff
(98.9 %id)
TI_57179608   CCM2.vn 448 to 1326 31 to 908       878/908
(96 %)
12 diff
(98.7 %id)
BI771872 pooled lung and spleen CCM2.vn 452 to 1326 1 to 873       873/873
(100 %)
6 diff
(99.4 %id)
TI_57187476   CCM2.vn 452 to 1328 48 to 919       872/873
(99 %)
24 diff
(97.3 %id)
BI857510 breast, mammary adenocarcinoma, cell line CCM2.vn 453 to 1328 1 to 871       871/872
(99 %)
24 diff
(97.3 %id)
BQ438969 embryonal carcinoma, cell line, testis CCM2.vn 456 to 1239 1 to 791       791/873
(90 %)
13 diff
(98.6 %id)
BG171183 hypernephroma, cell line, Kidney CCM2.vn 489 to 1274 1 to 780       780/924
(84 %)
22 diff
(97.7 %id)
TI_1948130084   CCM2.vn 489 to 1414 1044 to 115 *143C     930/1486
(62 %)
31 diff
(98.0 %id)
BQ304895 breast CCM2.vn 503 to 838 10 to 344       335/344
(97 %)
13 diff
(96.3 %id)
BM562251 amelanotic melanoma, cell line, skin CCM2.vn 516 to 1319 17 to 835       819/994
(82 %)
25 diff
(97.5 %id)
BM009198 amelanotic melanoma, cell line, skin CCM2.vn 522 to 1359 1 to 844       844/919
(91 %)
16 diff
(98.3 %id)
TI_59383917   CCM2.vn 522 to 1359 150 to 993       844/919
(91 %)
16 diff
(98.3 %id)
TI_1948130426   CCM2.vn 546 to 1414 990 to 123 *143C     868/1102
(78 %)
26 diff
(97.7 %id)
TI_1948130085   CCM2.vn 547 to 1414 990 to 121 *143C     870/1106
(78 %)
22 diff
(98.1 %id)
TI_1948130425   CCM2.vn 548 to 1414 979 to 115 *143C     865/1339
(64 %)
11 diff
(99.2 %id)
CB216218 normal endometrium, mid-secretory phase,cycle day 23, uterus CCM2.vn 558 to 1099 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BG422329 Kidney, renal cell adenocarcinoma CCM2.vn 596 to 1121 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
BC025958.
matches multiple genes
Kidney, Kidney, renal cell adenocarcinoma, renal cell adenocarcinoma CCM2.vn 597 to 1803 1 to 1207   available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base), also hits gene NFE2L3 1207/1207
(100 %)
0 diff
(100 %id)
BM542350 melanotic melanoma, skin CCM2.vn 601 to 1485 33 to 925 D117G E118*     893/1009
(88 %)
22 diff
(97.9 %id)
BE939303 testis_normal CCM2.vn 602 to 1052 1 to 450       450/451
(99 %)
4 diff
(99.2 %id)
BE395407 endometrium, adenocarcinoma cell line, uterus CCM2.vn 678 to 1198 1 to 521       521/521
(100 %)
0 diff
(100 %id)
AA121077 Pancreas CCM2.vn 680 to 1090 1 to 413       413/413
(100 %)
5 diff
(98.8 %id)
BF905768 marrow CCM2.vn 685 to 924 27 to 266       240/266
(90 %)
12 diff
(95.5 %id)
BX337465 Placenta Cot 25-normalized CCM2.vn 701 to 1695 990 to 1 L2A T3G L4X K7R A18E ...     992/990
(100 %)
16 diff
(98.4 %id)
TI_1948129740   CCM2.vn 745 to 1414 794 to 118 *143C     677/1448
(46 %)
13 diff
(99.2 %id)
BG675990 skin, squamous cell carcinoma CCM2.vn 750 to 1523 1 to 775       775/775
(100 %)
2 diff
(99.8 %id)
BM912297 amelanotic melanoma, cell line, skin CCM2.vn 761 to 1523 12 to 779       768/1078
(71 %)
21 diff
(98.1 %id)
BF663191 B-cells, primary B-cells from tonsils (cell line) CCM2.vn 768 to 1525 1 to 756 I70M G71A V72*     756/858
(88 %)
12 diff
(98.7 %id)
BF663932 B-cells, primary B-cells from tonsils (cell line) CCM2.vn 768 to 1614 1 to 831 F83L G84A R85G H86T R87G ...     831/893
(93 %)
25 diff
(97.3 %id)
BG341560 B-cells, primary B-cells from tonsils (cell line) CCM2.vn 768 to 1428 1 to 661       661/661
(100 %)
0 diff
(100 %id)
BM911961 amelanotic melanoma, cell line, skin CCM2.vn 769 to 1359 1 to 591       591/1142
(51 %)
16 diff
(98.6 %id)
BM471209 melanotic melanoma, skin CCM2.vn 769 to 1697 1 to 930       930/985
(94 %)
18 diff
(98.2 %id)
BE393442 endometrium, adenocarcinoma cell line, uterus CCM2.vn 772 to 1444 1 to 670 R110P S111V A112G P113T S114L ...     670/686
(97 %)
18 diff
(97.4 %id)
BQ059302 lymph, lymphoma, cell line CCM2.vn 774 to 1661 1 to 896       896/1043
(85 %)
15 diff
(98.6 %id)
BQ059731 lymph, lymphoma, cell line CCM2.vn 774 to 1428 1 to 660 E57D K58N G77D R102T S106N ...     660/1001
(65 %)
30 diff
(97.1 %id)
BM699830 eye, lens CCM2.vn 777 to 1234 1 to 458     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
BU902107 leiomyosarcoma, uterus CCM2.vn 783 to 1803 5 to 1023   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1019/1024
(99 %)
37 diff
(96.4 %id)
BX431944 fetal liver, Liver CCM2.vn 787 to 1594 1 to 809 D125A I126S S127A S128A D129T ...     809/952
(84 %)
28 diff
(97.1 %id)
BF129119 B-cells, primary B-cells from tonsils (cell line) CCM2.vn 788 to 1552 1 to 760 M122*     760/922
(82 %)
28 diff
(97.0 %id)
BQ687060 ductal carcinoma, cell line, Pancreas CCM2.vn 793 to 1680 1 to 899       899/956
(94 %)
12 diff
(98.8 %id)
BQ919522 carcinoma, cell line, Prostate CCM2.vn 799 to 1608 21 to 836 S9A P53A Q139X     816/937
(87 %)
28 diff
(97.1 %id)
BQ958962 carcinoma, cell line, Prostate CCM2.vn 800 to 1693 1 to 899       899/984
(91 %)
21 diff
(97.9 %id)
BE788377 large cell carcinoma, lung CCM2.vn 803 to 1373 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
CR596053 Placenta Cot 25-normalized CCM2.vn 819 to 1775 1 to 957       957/957
(100 %)
0 diff
(100 %id)
BX396912 Placenta Cot 25-normalized CCM2.vn 819 to 1074 1 to 257   fully sequenced,   257/257
(100 %)
1 diff
(99.7 %id)
BX365021 Placenta Cot 25-normalized CCM2.vn 819 to 1700 951 to 76 L4C R5A T6P K7X L8C ...     879/1052
(83 %)
24 diff
(97.8 %id)
BG119947 adenocarcinoma, cell line, Liver CCM2.vn 819 to 1506 15 to 698 F83L G84A R85G H86T R87G ...     684/746
(91 %)
19 diff
(97.5 %id)
CD633182   CCM2.vn 822 to 910 1 to 88       88/101
(87 %)
2 diff
(98.1 %id)
CD633183   CCM2.vn 822 to 910 100 to 13       88/100
(88 %)
0 diff
(100 %id)
BM543271 duodenal adenocarcinoma, cell line, small intestine CCM2.vn 824 to 1624 37 to 851       815/1123
(72 %)
31 diff
(97.3 %id)
TI_1948129741   CCM2.vn 825 to 1414 714 to 123 *143C     592/1137
(52 %)
3 diff
(99.8 %id)
BM014698 breast, mammary adenocarcinoma, cell line CCM2.vn 832 to 1557 1 to 730       730/730
(100 %)
10 diff
(98.7 %id)
TI_59392746   CCM2.vn 832 to 1557 89 to 818       730/730
(100 %)
10 diff
(98.7 %id)
BM701704 eye, optic nerve CCM2.vn 832 to 1358 1 to 526   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 526/526
(100 %)
1 diff
(99.9 %id)
BG004344 placenta_normal CCM2.vn 855 to 1261 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
BI519830 leukocyte CCM2.vn 861 to 1712 880 to 19 E22R Y23V R24P N25Q G26W ...     861/880
(97 %)
18 diff
(98.0 %id)
TI_44460300   CCM2.vn 861 to 1712 880 to 19 E22R Y23V R24P N25Q G26W ...     861/880
(97 %)
18 diff
(98.0 %id)
BM710866 eye, fetal eyes CCM2.vn 877 to 1351 1 to 475   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 475/475
(100 %)
4 diff
(99.2 %id)
TI_154192603   CCM2.vn 880 to 1513 65 to 696 E57X E131*     632/1081
(58 %)
17 diff
(98.5 %id)
TI_1948129393   CCM2.vn 882 to 1414 655 to 122 L2A L4M Q15A F16V A17C ...     534/1040
(51 %)
23 diff
(97.8 %id)
AA236101 germinal center B cell CCM2.vn 888 to 1318 1 to 430       430/431
(99 %)
14 diff
(96.8 %id)
BG745079 blood, natural killer cells, cell line CCM2.vn 893 to 1741 854 to 1 E12G I13D Q14P Q15A F16V ...     854/914
(93 %)
13 diff
(98.6 %id)
BM826572 Ascites, stomach CCM2.vn 895 to 1455 1 to 561 A142X     561/561
(100 %)
0 diff
(100 %id)
BG995306 head_neck CCM2.vn 901 to 1209 306 to 2       306/307
(99 %)
3 diff
(99.1 %id)
BQ063829 lymph, lymphoma, cell line CCM2.vn 919 to 1750 1 to 844 S114L     844/1068
(79 %)
24 diff
(97.8 %id)
AW407304 lymph CCM2.vn 920 to 1230 1 to 311       311/311
(100 %)
5 diff
(98.4 %id)
TI_154145277   CCM2.vn 926 to 1553 103 to 737 A112G P113T     635/925
(68 %)
21 diff
(97.8 %id)
TI_154146429   CCM2.vn 926 to 1529 83 to 684 S128N S136T D138G     602/602
(100 %)
21 diff
(96.6 %id)
BU602389 mixed (pool of 40 RNAs) CCM2.vn 944 to 1693 1 to 754       754/774
(97 %)
7 diff
(99.1 %id)
BF988670 placenta_normal CCM2.vn 955 to 1427 481 to 10 K7N K58*     472/481
(98 %)
2 diff
(99.6 %id)
BU930943 ovary, teratocarcinoma, cell line CCM2.vn 964 to 1785 827 to 1 L2A T3D L4R R5C T6A ...   Submitted on the opposite strand 827/858
(96 %)
7 diff
(99.2 %id)
BG756208 B-cells, primary B-cells from tonsils (cell line) CCM2.vn 968 to 1722 1 to 752       752/999
(75 %)
6 diff
(99.4 %id)
BF992688 placenta_normal CCM2.vn 985 to 1370 388 to 4       385/388
(99 %)
0 diff
(100 %id)
BQ233232 epithelioid carcinoma, Pancreas CCM2.vn 989 to 1803 835 to 19   AAA Submitted on the opposite strand 817/873
(93 %)
8 diff
(99.1 %id)
TI_149285451   CCM2.vn 992 to 1789 888 to 95   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 794/1080
(73 %)
8 diff
(99.3 %id)
TI_149312616   CCM2.vn 993 to 1817 899 to 89   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 811/955
(84 %)
14 diff
(98.6 %id)
BF990171 placenta_normal CCM2.vn 994 to 1426 434 to 2       433/434
(99 %)
0 diff
(100 %id)
BE619930 large cell carcinoma, lung CCM2.vn 1004 to 1495 492 to 1       492/492
(100 %)
2 diff
(99.6 %id)
BM826085 Ascites, stomach CCM2.vn 1007 to 1382 1 to 376       376/376
(100 %)
0 diff
(100 %id)
CF130605 Chondrosarcoma Lung Metastasis cell lines, lung CCM2.vn 1015 to 1423 1 to 409       409/409
(100 %)
1 diff
(99.8 %id)
BQ366586 placenta_normal CCM2.vn 1021 to 1376 368 to 8       361/368
(98 %)
0 diff
(100 %id)
DA314978 hippocampus CCM2.vn 1025 to 1556 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BF989112 placenta_normal CCM2.vn 1028 to 1228 227 to 28       200/227
(88 %)
0 diff
(100 %id)
BX330890   CCM2.vn 1033 to 1799 765 to 1       765/809
(94 %)
39 diff
(95.2 %id)
TI_154194330   CCM2.vn 1039 to 1804 39 to 802       764/806
(94 %)
19 diff
(97.7 %id)
BX396911 Placenta Cot 25-normalized CCM2.vn 1044 to 1751 731 to 25   fully sequenced,   707/731
(96 %)
1 diff
(99.9 %id)
BE544969 cervical carcinoma cell line, cervix CCM2.vn 1045 to 1496 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
CF128450 Chondrosarcoma Lung Metastasis cell lines, lung CCM2.vn 1048 to 1763 1 to 717       717/717
(100 %)
5 diff
(99.4 %id)
AA084808   CCM2.vn 1050 to 1390 1 to 346       346/350
(98 %)
19 diff
(94.6 %id)
BM978173 lung CCM2.vn 1078 to 1817 752 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 734/734
(100 %)
6 diff
(99.2 %id)
BM805785 brain, hippocampus CCM2.vn 1101 to 1523 1 to 423       423/1300
(32 %)
1 diff
(100.0 %id)
CA427018 Bone, Subchondral Bone CCM2.vn 1104 to 1803 718 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
BG403148 bladder, transitional cell papilloma, cell line CCM2.vn 1116 to 1779 1 to 663       663/663
(100 %)
3 diff
(99.6 %id)
TI_149283994   CCM2.vn 1124 to 1803 758 to 80   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 679/703
(96 %)
2 diff
(99.8 %id)
BI524553 pooled lung and spleen CCM2.vn 1129 to 1509 404 to 1       404/720
(56 %)
12 diff
(98.4 %id)
TI_44159375   CCM2.vn 1129 to 1745 627 to 3       625/951
(65 %)
0 diff
(100 %id)
CA432433 cell lines, Chondrosarcoma CCM2.vn 1129 to 1817 706 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 688/688
(100 %)
2 diff
(99.8 %id)
BM984872 lung CCM2.vn 1133 to 1789 675 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 657/657
(100 %)
2 diff
(99.7 %id)
BM984367 lung CCM2.vn 1136 to 1803 686 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 668/670
(99 %)
0 diff
(100 %id)
BE929165 placenta_normal CCM2.vn 1139 to 1250 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
CD743181 Alveolar Macrophage, lung CCM2.vn 1141 to 1803 681 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 663/663
(100 %)
3 diff
(99.6 %id)
BU527232 epidermoid carcinoma, cell line, lung CCM2.vn 1156 to 1803 1 to 648   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 648/648
(100 %)
1 diff
(99.9 %id)
BG107752 Bone, osteosarcoma, cell line CCM2.vn 1171 to 1789 1 to 617   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 617/617
(100 %)
2 diff
(99.7 %id)
BU621674 cell lines, Chondrosarcoma CCM2.vn 1178 to 1817 658 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 640/640
(100 %)
1 diff
(99.9 %id)
CB528698 Aveolar Macrophage, lung CCM2.vn 1181 to 1817 654 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 636/636
(100 %)
1 diff
(99.9 %id)
BX383604   CCM2.vn 1191 to 1723 555 to 18       538/555
(96 %)
0 diff
(100 %id)
BI093031 cervix CCM2.vn 1194 to 1800 1 to 607   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 607/608
(99 %)
1 diff
(99.9 %id)
AA642981 lymph node, lymphoma CCM2.vn 1245 to 1805 563 to 4       560/563
(99 %)
0 diff
(100 %id)
AI829096 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) CCM2.vn 1257 to 1805 551 to 3       549/551
(99 %)
0 diff
(100 %id)
BP396788 pancreatic islet CCM2.vn 1262 to 1805 1 to 545     Submitted on the opposite strand 545/547
(99 %)
2 diff
(99.7 %id)
BM706336 eye, lens CCM2.vn 1264 to 1631 10 to 377   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 368/377
(97 %)
7 diff
(98.2 %id)
T55953 fetal spleen, Spleen CCM2.vn 1271 to 1478 1 to 211   fully sequenced,   211/211
(100 %)
1 diff
(99.6 %id)
AW071985 anaplastic oligodendroglioma, brain CCM2.vn 1289 to 1772 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
AI871224 anaplastic oligodendroglioma, brain CCM2.vn 1295 to 1795 502 to 1       502/502
(100 %)
9 diff
(98.3 %id)
AW152343 serous papillary carcinoma, high grade, 2pooled tumors, uterus CCM2.vn 1295 to 1804 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
BQ020699 Fibrosarcoma CCM2.vn 1311 to 1821 525 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 511/511
(100 %)
4 diff
(99.3 %id)
AW512523 lymph node, lymphoma, follicular mixed small and largecell CCM2.vn 1320 to 1800 484 to 4       481/484
(99 %)
0 diff
(100 %id)
BM667711 eye, fetal eyes CCM2.vn 1321 to 1789 487 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
AI623713 serous papillary carcinoma, high grade, 2pooled tumors, uterus CCM2.vn 1322 to 1805 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
AI762266 B-cell, chronic lymphotic leukemia CCM2.vn 1322 to 1790 470 to 1       470/470
(100 %)
4 diff
(99.2 %id)
BM666564 eye, optic nerve CCM2.vn 1328 to 1803 494 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 476/476
(100 %)
1 diff
(99.8 %id)
AI978921 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors CCM2.vn 1330 to 1819 495 to 6       490/496
(98 %)
0 diff
(100 %id)
BG222467 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification CCM2.vn 1330 to 1804 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
BG117454 adenocarcinoma, cell line, Liver CCM2.vn 1336 to 1803 11 to 478   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 468/478
(97 %)
11 diff
(97.7 %id)
AW117876 esophagus, squamous cell carcinoma CCM2.vn 1340 to 1789 451 to 1       451/451
(100 %)
2 diff
(99.6 %id)
BX456540 thymus CCM2.vn 1341 to 1800 1 to 460   fully sequenced,   460/460
(100 %)
2 diff
(99.6 %id)
AI494363 B-cell, chronic lymphotic leukemia CCM2.vn 1341 to 1790 450 to 1       450/450
(100 %)
6 diff
(98.7 %id)
H62064 ovarian tumor, ovary CCM2.vn 1342 to 1591 1 to 250   fully sequenced,   250/250
(100 %)
6 diff
(97.6 %id)
DB565158 hypothalamus CCM2.vn 1343 to 1795 1 to 453     Submitted on the opposite strand 453/453
(100 %)
3 diff
(99.4 %id)
AA027200 heart CCM2.vn 1343 to 1539 1 to 198   fully sequenced,   198/198
(100 %)
7 diff
(96.5 %id)
AI677795 adenocarcinoma, Pancreas CCM2.vn 1343 to 1800 464 to 6       459/464
(98 %)
0 diff
(100 %id)
BG222393 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification CCM2.vn 1356 to 1805 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
BF593492 Prostate CCM2.vn 1359 to 1800 443 to 2       442/443
(99 %)
0 diff
(100 %id)
AW009386 colon CCM2.vn 1377 to 1791 416 to 2       415/416
(99 %)
0 diff
(100 %id)
AI672747 thymus, pooled CCM2.vn 1378 to 1804 429 to 1       429/429
(100 %)
5 diff
(98.9 %id)
CN478471 eye, lens CCM2.vn 1378 to 1803 444 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 426/427
(99 %)
1 diff
(99.8 %id)
DB564482 hypothalamus CCM2.vn 1379 to 1805 1 to 429     Submitted on the opposite strand 429/436
(98 %)
5 diff
(98.9 %id)
BF059020 fibrotheoma, ovary CCM2.vn 1379 to 1789 411 to 1       411/411
(100 %)
0 diff
(100 %id)
CR989470 T-Lymphocytes CCM2.vn 1380 to 1795 1 to 416   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 416/416
(100 %)
0 diff
(100 %id)
BU727891 eye, optic nerve CCM2.vn 1380 to 1803 442 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 424/424
(100 %)
1 diff
(99.8 %id)
AA653968 epithelium (cell line), Prostate CCM2.vn 1399 to 1805 405 to 1       405/405
(100 %)
9 diff
(97.8 %id)
AA889703   CCM2.vn 1399 to 1791 392 to 2       391/392
(99 %)
0 diff
(100 %id)
AI660303 thymus, pooled CCM2.vn 1409 to 1803 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BX341117   CCM2.vn 1410 to 1767 380 to 6       375/412
(91 %)
0 diff
(100 %id)
AI129215 uterus CCM2.vn 1419 to 1803 387 to 1       387/387
(100 %)
8 diff
(98.0 %id)
BM686319 eye, eye anterior segment CCM2.vn 1420 to 1805 1 to 386       386/410
(94 %)
2 diff
(99.6 %id)
AA725435 parathyroid gland, parathyroid tumor CCM2.vn 1423 to 1819 399 to 5       395/402
(98 %)
0 diff
(100 %id)
AI568693 B-cell, chronic lymphotic leukemia CCM2.vn 1437 to 1797 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AI633328 Kidney, renal cell tumor CCM2.vn 1439 to 1805 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
BF477444 brain, glioblastoma (pooled) CCM2.vn 1439 to 1803 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AI566555 anaplastic oligodendroglioma, brain CCM2.vn 1441 to 1803 363 to 1       363/363
(100 %)
2 diff
(99.5 %id)
T57200 fetal spleen, Spleen CCM2.vn 1448 to 1803 356 to 1   fully sequenced,   356/356
(100 %)
7 diff
(98.1 %id)
AI424429 Prostate CCM2.vn 1464 to 1789 339 to 14   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 326/326
(100 %)
0 diff
(100 %id)
AI686112 Prostate CCM2.vn 1464 to 1791 331 to 4       328/331
(99 %)
0 diff
(100 %id)
AI659610 Prostate CCM2.vn 1464 to 1791 330 to 3       328/330
(99 %)
0 diff
(100 %id)
BF002948 Prostate CCM2.vn 1464 to 1791 330 to 3       328/330
(99 %)
0 diff
(100 %id)
AW072937 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma CCM2.vn 1468 to 1797 330 to 1       330/330
(100 %)
0 diff
(100 %id)
AA027201 heart CCM2.vn 1509 to 1798 293 to 1   fully sequenced,   293/293
(100 %)
9 diff
(97.0 %id)
AI220314 pooled CCM2.vn 1516 to 1803 288 to 1       288/288
(100 %)
0 diff
(100 %id)
AW779526 colon, moderately-differentiated adenocarcinoma CCM2.vn 1516 to 1817 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
AA084809   CCM2.vn 1520 to 1819 301 to 5       297/326
(91 %)
0 diff
(100 %id)
BU071863 insulinoma, Pancreas CCM2.vn 1521 to 1817 1 to 297   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 297/297
(100 %)
4 diff
(98.7 %id)
AA903402 pooled germ cell tumors CCM2.vn 1524 to 1803 297 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 280/280
(100 %)
2 diff
(99.3 %id)
BF002962 Prostate CCM2.vn 1524 to 1819 301 to 6       296/301
(98 %)
0 diff
(100 %id)
BQ549236 insulinoma, Pancreas CCM2.vn 1525 to 1803 7 to 286   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 280/286
(97 %)
1 diff
(99.7 %id)
BM512141 insulinoma, Pancreas CCM2.vn 1527 to 1817 7 to 298   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 292/298
(97 %)
1 diff
(99.7 %id)
AW009784 colon CCM2.vn 1528 to 1789 282 to 21   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 262/262
(100 %)
8 diff
(97.0 %id)
AI538498 B-cell, chronic lymphotic leukemia CCM2.vn 1531 to 1821 302 to 12   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
BQ549719 insulinoma, Pancreas CCM2.vn 1533 to 1629 97 to 1       97/97
(100 %)
0 diff
(100 %id)
CK826242 insulinoma, Pancreas CCM2.vn 1533 to 1795 263 to 1       263/263
(100 %)
1 diff
(99.7 %id)
AA235819 germinal center B cell CCM2.vn 1536 to 1802 267 to 1       267/267
(100 %)
2 diff
(99.3 %id)
AW083416 colon, moderately differentiated adenocarcinoma CCM2.vn 1537 to 1797 261 to 1       261/261
(100 %)
3 diff
(98.9 %id)
AW087223 colon, moderately differentiated adenocarcinoma CCM2.vn 1544 to 1797 254 to 1       254/254
(100 %)
0 diff
(100 %id)
BX456539 thymus CCM2.vn 1549 to 1771 221 to 1   fully sequenced,   221/221
(100 %)
3 diff
(98.7 %id)
BF436964 Prostate CCM2.vn 1551 to 1790 243 to 4       240/243
(98 %)
0 diff
(100 %id)
AI650521 pooled germ cell tumors CCM2.vn 1553 to 1789 237 to 1       237/237
(100 %)
0 diff
(100 %id)
BF591112 colon, colon tumor, RER+ CCM2.vn 1558 to 1802 245 to 1       245/245
(100 %)
1 diff
(99.6 %id)
H61158 ovarian tumor, ovary CCM2.vn 1561 to 1755 195 to 1   fully sequenced,   195/195
(100 %)
2 diff
(99.0 %id)
AA293409 ovarian tumor, ovary CCM2.vn 1588 to 1795 1 to 206   fully sequenced,   206/206
(100 %)
6 diff
(97.1 %id)
BU734715 eye, lens CCM2.vn 1601 to 1803 221 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 203/203
(100 %)
0 diff
(100 %id)
AA399478 ovarian tumor, ovary CCM2.vn 1636 to 1794 159 to 1   fully sequenced,   159/159
(100 %)
0 diff
(100 %id)
BG532786 embryonal carcinoma, testis CCM2.vo 1 to 732 1 to 755   tiling clone,   755/867
(87 %)
10 diff
(98.9 %id)
CV572216 cornea, eye CCM2.vo 419 to 1016 1 to 598   tiling clone,   598/598
(100 %)
1 diff
(99.9 %id)
TI_154186195   CCM2.vo 715 to 1578 121 to 978 exact tiling clone,   858/978
(87 %)
16 diff
(98.4 %id)
DA082426 cerebellum CCM2.vp 45 to 574 34 to 563   tiling clone, capped Suspected internal deletion 562/562
(100 %)
0 diff
(100 %id)
BQ229937 embryonal carcinoma, cell line, testis CCM2.vp 45 to 310 38 to 303     Suspected internal deletion 303/307
(98 %)
1 diff
(99.7 %id)
TI_57235314   CCM2.vp 317 to 1080 59 to 822 exact     764/822
(92 %)
9 diff
(99.0 %id)
BI909266 leukocyte CCM2.vp 327 to 1080 1 to 753 exact tiling clone,   753/753
(100 %)
3 diff
(99.7 %id)
BX952954   CCM2.vq-u 1 to 479 1 to 479 exact tiling clone,   479/479
(100 %)
0 diff
(100 %id)
BG956883 colon CCM2.vr-u 1 to 286 11 to 296 G2C P6Q R7D Q8R K9R ... tiling clone,   286/305
(93 %)
15 diff
(95.1 %id)
BF751086 breast_normal CCM2.vs-u 1 to 199 1 to 199 L8C S9L T11H F12S S13A ... tiling clone,   199/213
(93 %)
8 diff
(96.3 %id)
AA302657 adipose tissue, white Gene CCM2, variant not shown              
DB299238 cerebellum Gene CCM2, variant not shown              
DA102373 cerebellum Gene CCM2, variant not shown       capped      
DA132842 alzheimer cortex Gene CCM2, variant not shown       capped This clone was ignored    
BX118027 whole brain Gene CCM2, variant not shown       AAA      
DA420491 cervix Gene CCM2, variant not shown       capped This clone was ignored    
CN333899 embryonic stem cells, DMSO-treated H9 cellline Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
CN333900 embryonic stem cells, DMSO-treated H9 cellline Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
BX415189 thymus Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
BX415190 thymus Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
BX355050 Neuroblastoma Cot 25-normalized Gene CCM2, variant not shown       fully sequenced, This clone was ignored    
BX355051 Neuroblastoma Cot 25-normalized Gene CCM2, variant not shown       fully sequenced, This clone was ignored    
BP226627   Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
DB545550 hippocampus Gene CCM2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BP263334 small intestine Gene CCM2, variant not shown         This clone was ignored    
AA593002 colon, colon tumor RER+ Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
AA811689 germinal center B cell Gene CCM2, variant not shown              
AI969269 pooled germ cell tumors Gene CCM2, variant not shown              
AW250337 lung, small cell carcinoma Gene CCM2, variant not shown         This clone was ignored    
AW251072 lung, small cell carcinoma Gene CCM2, variant not shown       AAA This clone was ignored    
BE314124 brain, neuroblastoma Gene CCM2, variant not shown         This clone was ignored    
BC063663 Colon, adenocarcinoma Gene CCM2, variant not shown       available from MGC, AAA This clone was ignored    
BF310219 brain, neuroblastoma Gene CCM2, variant not shown         This clone was ignored    
BI752347 brain Gene CCM2, variant not shown         This clone was ignored    
BI767109 pooled lung and spleen Gene CCM2, variant not shown         This clone was ignored    
BQ668875 epidermoid carcinoma, cell line, salivary gland Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57178785   Gene CCM2, variant not shown         This clone was ignored    
CB123887 Liver Gene CCM2, variant not shown         This clone was ignored    
DA820948 pericardium Gene CCM2, variant not shown       capped This clone was ignored    
DB115362 thymus Gene CCM2, variant not shown       capped This clone was ignored    
TI_157613093   Gene CCM2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CF528009 placenta Gene CCM2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BM667905 eye, lens Gene CCM2, variant not shown       AAA This clone was ignored    
BM696552 eye, lens Gene CCM2, variant not shown         This clone was ignored    
BM668083 eye, lens Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
BM697136 eye, lens Gene CCM2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl-u, .vm, .vn, .vo, .vp, .vq-u, .vr-u, .vs-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC